Clinical Trial

Prevalence of H. Pylori in Stomach Cancers in the West Indies

Study acronym: PyloCaGe
Recruiting
View on ClinicalTrials.gov →
Summary
The incidence and mortality of stomach cancer are higher in the French West Indies than in mainland France. The prevalence of H. pylori infection associated with this cancer remains unknown in these populations. The main objective of the study is to estimate the prevalence of H. Pylori detected by immunohistochemistry in patients newly diagnosed with cancer.
Trial Details
NCT Number NCT07233447
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Conditions Oncology Epidemiology, Risk Factors
Enrollment 100 participants
Start Date 2025-02-24
Primary Completion 2027-02-24 (estimated)
Study Completion 2027-02-24 (estimated)
Updated on ClinicalTrials.gov 2025-11-18